, Nov. 11 (GenomeWeb News) - Simulations Plus has acquired all assets of Santa Fe, NM-based cheminformatics firm Bioreason in an all-cash transaction worth approximately $788,000.
Through the transaction, Simulations Plus acquired software, source code, two patents, trademarks, marketing and sales information, and all other fixed assets.
Simulations Plus said that Bioreason's flagship software, ClassPharmer will be integrated into a single product with Sage Informatics ChemTK package.
ClassPharmer is currently licensed to over 30 companies in the
Momoko Beran, chief financial officer of Simulations Plus, said in a statement that Bioreason's assets include nearly $400,000 in accounts receivable from multi-year licenses, "with some of these due as early as this month. Most companies license on an annual basis, and if all licenses that will expire during this fiscal year are renewed, revenues from such licenses would exceed $500,000."
This article originally appeared in BioInform, a GenomeWeb News sister publication.